Karla Lundy
Family · Woodmere, OHNPI 1487298279
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 229 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 24.2% of the total. Reporting peaked in 2022 at $2,669 and has fallen 98.4% since, to $43 in 2025. Among family clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 229 payments — averaging $20.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- LEO Pharma Inc.$633
- Sanofi$537
- E.r. Squibb & Sons, L.L.C.$310
- Regeneron Healthcare Solutions, Inc.$294
- Lilly USA, LLC$273
- plus $1K from 16 others
What the payments were for
- Food & beverage$4,48298%
- Education$1002%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 59 | $1,109 |
| LEO Pharma Inc. | 44 | $633 |
| Sanofi | 23 | $537 |
| E.r. Squibb & Sons, L.L.C. | 11 | $310 |
| Regeneron Healthcare Solutions, Inc. | 13 | $294 |
| Lilly USA, LLC | 14 | $273 |
| Novartis | 17 | $242 |
| Dermavant Sciences, Inc. | 3 | $186 |
| Amgen | 8 | $164 |
| Incyte Corporation | 7 | $139 |
| UCB, Inc. | 6 | $127 |
| Boehringer Ingelheim | 5 | $126 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Sun Pharmaceutical Industries Inc. | 4 | $83 |
| Johnson & Johnson | 4 | $72 |
| Pfizer | 4 | $60 |
| Medtronic | 1 | $25 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $25 |
| Dexcom, Inc. | 1 | $22 |
| Exact Sciences | 1 | $20 |
| Galderma Laboratories, L.p. | 1 | $19 |
| Almirall LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,582 in reported general payments places this provider in the 90th percentile of 6,812 family providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 15 | $208,728 |
| Clindamycin Phosphate | 21 | $982 |
| Clobetasol Propionate | 16 | $963 |
| Triamcinolone Acetonide | 35 | $355 |
| Ketoconazole | 20 | $258 |
| Hydroxyzine Hcl | 13 | $254 |
Paid to pharmacies, not to this prescriber.
Other family in Woodmere
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
- Florence StewartNew Albany$113K
- Kirt MunsonToledo$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.